Retatrutide (20mg)
$115.00
Retatrutide is a premium research peptide currently being studied for its unique triple-receptor activity involving GLP-1, GIP, and glucagon receptors. Manufactured for laboratory research, each vial is tested for purity and quality to support reliable and consistent research applications. For research use only. Not for human or veterinary use.
Retatrutide, also identified as LY3437943, is an investigational peptide studied for its activity across three metabolic receptor pathways: GLP-1, GIP, and glucagon receptors. This triple-receptor mechanism has made it an important compound of interest in controlled research involving metabolic signaling, energy balance, glucose regulation, and related biological processes.
Each vial from Atlas Peptide Co. is independently laboratory tested to verify identity, purity, and quality.
Product Details
- Research-grade peptide
- Laboratory-tested purity
- Lyophilized powder
- Stored and shipped with quality in mind
- Certificate of Analysis available, when applicable
Important Notice: Retatrutide is an investigational compound and is not currently approved by the FDA. This product is sold strictly for laboratory research purposes only. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of any disease.
Frequently bought together
-
CJC 1295 no DAC + Ipamorelin (10mg)
$65.00 -
KLOW (80mg)
$115.00 -
MOTS-C (40mg)
$95.00 -
Retatrutide (30mg)
$145.00 -
Tesamorelin (10mg)
$140.00